Markets

Will Japan's first stem-cell treatment for Parkinson’s disease be commercially available by the end of 2026?

Yes0%No0%
Loading...

About this market

This market resolves to Yes if the stem-cell treatment for Parkinson’s disease, approved by Japan for manufacturing and sale, becomes commercially available to the public by December 31, 2026. Availability must be verifiable through a reputable announcement by Sumitomo Pharma or a reliable news source.

Rules

  • Market closes at 12/31/2026.
  • Logic weighted resolution applies.